Target intelligence / Profile preview

Small ribosomal subunit protein mS39, mitochondrial (PTCD3)

Target
PTCD3
Molecular classification
Other (mitochondrial ribosomal protein, RNA-binding protein)
01

Overview

Small ribosomal subunit protein mS39, mitochondrial (PTCD3) is a mitochondrial RNA-binding protein that is a component of the mitochondrial small ribosomal subunit, playing a crucial role in mitochondrial translation by binding rRNA and contributing to the assembly and function of the mitochondrial ribosome. Mutations in PTCD3 have been associated with combined oxidative phosphorylation deficiency 51, implicating its importance in mitochondrial respiratory chain function[1][2][7][8]. Notes: - PTCD3 is not a typical therapeutic target such as a receptor, enzyme, transporter, or transcription factor, but rather a structural/functional ribosomal protein essential for mitochondrial gene expression and respiratory function[1][7][8]. - There are no known drugs or small molecules directly targeting PTCD3; thus, no mechanisms of action, biomarkers, or safety concerns directly related to therapeutics are reported for this molecule. - Aliases provided here are based on common entries in gene/protein databases and literature[1][8].

Other names
Pentatricopeptide repeat domain 3MRPS39TRG15MRP-S39TRG-15FLJ20758DKFZp666K071mS3928S ribosomal protein S39, mitochondrialPentatricopeptide repeat domain-containing protein 3, mitochondrialTransformation-related gene 15 proteinCOXPD51
02

Biological functions

Mitochondrial translationrRNA bindingRibosomal small subunit binding
03

Disease associations

Mitochondrial disease (e.g., combined oxidative phosphorylation deficiency 51)Other (mitochondrial dysfunction-related diseases)

Beyond the preview

Go deeper on Small ribosomal subunit protein mS39, mitochondrial (PTCD3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small ribosomal subunit protein mS39, mitochondrial (PTCD3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call